Abiopharma

Director Bunina Elena 🔴 sold 10.8K shares of Nebius Group N.V. (NBIS) at $190.00 ($2.0M) Transaction Date: May 06, 2026 | Filing ID: 000055

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001918704-26-012540 <b>Size:</b> 809 KB

(30% Negative) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Reports Q2 2026 Financial Results

(99% Neutral) STRAN & COMPANY, INC. (SWAGW) Files Form 8-K

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

Global Payments Expands Partnership with Lightspeed DMS to Power Embedded Payments for Dealerships

Cellebrite annonce sa participation à plusieurs conférences dinvestisseurs USA - Français APAC - Thai Israel - English MEXICO - Spanish BRAZIL - Portuguese Japan - Japanese Korea - 한국어 USA - Deutsch USA - español APAC - English

Cellebrite kündigt Teilnahme an bevorstehenden Investorenkonferenzen an USA - Deutsch APAC - Thai Israel - English USA - Français MEXICO - Spanish BRAZIL - Portuguese APAC - English Japan - Japanese Korea - 한국어 USA - español

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

Draganfly Flex FPV Drone Selected by Two Additional U.S. Department of War Units

Stran & Company Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Arbor Realty Trust Reports First Quarter 2026 Results and Declares Dividend of $0.17 per Share

Skycorp to Hold Extraordinary General Meeting

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

Rush Street Interactive to Participate at the 21st Annual Needham Technology, Media, & Consumer Conference